Tissue Regenix rejigs loan agreement
Chairman John Samuel: "I am very pleased that Midcap have shown their support for the company by entering this revised agreement"
Company
Tissue Regenix Group PLC
LON:TRX
Tissue Regenix Group PLC is a pioneering, international medical technology company, focusing on the development of regenerative products utilising its two platform technologies, dCELL, addressing soft tissue needs, and BioRinse, providing sterile bone allografts. The company is currently helping to transform the treatment of patients in key surgical applications: biosurgery, orthopaedics (sports medicine/spine), dental, general, plastic surgery, urology/gynaecology, ophthalmology and cardiac.
255 stories · page 5 of 13
Tissue Regenix optimistic about MidCap covenant talks
“These discussions are progressing well and the board is optimistic of being able to agree a solution with MidCap Financial"
Tissue Regenix confirms US$300,000 grant for San Antonio facility
The regenerative medicine company said the funds would help upgrade utilities and infrastructure at the site
Tissue Regenix develops product extension to be used in female pelvic medicine
Interim chief executive Gareth Jones said: “Our commercial success is predicated on our ability to identify new clinical applications and rapidly develop product lines to meet this demand."
Tissue Regenix's production capacity increases should bear fruit in the second half
During the first half, the regenerative medicines specialist streamlined its logistics network and enhanced its operational procedures
Tissue Regenix appoints interim finance chief Barker to full-time role
The regenerative medical devices specialist said Mike Barker will join the board with immediate effect having held the role on an interim basis since the start of the year
Tissue Regenix adds manufacturing capacity in US expansion push
“Having commenced a second shift at the beginning of the year in our current facility in San Antonio, the phased build out of this new facility will allow us to meet the growing requirements of our customers well into the future," said boss
Archive
Proactive news snapshot: Digitalbox, Seeing Machines, Alba Minerals Resources...
A glance at some of the day's highlights from the Proactive Investors newswire
Tissue Regenix chief executive steps down as illness recurs
John Samuel will resume as executive chairman until a full-time chief executive is appointed
Investments and investor services
Fund manager Randeep Grewal appointed new chairman of BB Healthcare
Justin Stebbing is stepping down after three years in the role, and Randeep Grewal has been appointed as his successor with immediate effect
Archive
Proactive news snapshot: Active Energy, Be Heard Group, EQTEC, Horizonte Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Tissue Regenix secures US$20mln credit facility; says current trading is in line
“The additional capital secured through the credit facilities allows us to focus on further scaling the manufacturing capacity of the business and pursue further partnership opportunities, driving the business trajectory towards self-sustai
Investments and investor services
Cellcast downcast as Kenya ups the ante in attack on the gambling industry
A look at the day's major movers, including Topps Tiles, Mortgage Advice, Shoe Zone, Knight's Group, UDG, GYG and Galliford Try.
Archive
Proactive news snapshot: VR Education, IronRidge Resources, Sirius Minerals, Itaconix …
A glance at some of the day's highlights from the Proactive Investors newswire
Tissue Regenix boss to return to full-time duties in June
Steve Couldwell has been out of action so far this year while he undergoes medical treatment
Investments and investor services
Andalas subsides after finance director resigns
A look at the day's major movers, including Gordon Dadds, Motif Bio, Proton Power, Regal Petroleum, Saga and Xeros Technology
Archive
Proactive news snapshot: ReNeuron Group PLC, Tissue Regenix Group PLC, ANGLE PLC, Motif Bio PLC …
A glance at some of the day's highlights from the Proactive Investors newswire
Tissue Regenix secures additional coverage for DermaPure from a US Group Purchasing Organization
The AIM-listed firm said the additional coverage will open up access to a further 1,500 hospitals and 32,500 alternative care providers, primarily in the South Eastern region of the US
Investments and investor services
FTSE 100 closes in positive territory, boosted by better-than-expected US March jobs figures as Brexit uncertainty continues
Mid-cap cousin FTSE 250 was also lower, shedding around 56 points at 19,507
Tissue Regenix continues regeneration as it targets breaking even by 2020
Earlier this month, Tissue Regenix reported full-year results showing revenues more than doubled last year to £11.6mln, up from £5.2mln a year earlier